Litcius/Paper detail

Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea

Jii Bum Lee, Minkyu Jung, June Hyuk Kim, Bo Hyun Kim, Yeol Kim, Young Seok Kim, Byung Chang Kim, Jin Kim, Sung Ho Moon, Keon Uk Park, Meerim Park, Hyeon Jin Park, Sung Hoon Sim, Hong Man Yoon, Soo Jung Lee, Eunyoung Lee, June Young Chun, Youn Kyung Chung, So‐Youn Jung, Jinsoo Chung, Eun Sook Lee, Hyun Cheol Chung, Tak Yun, Sun Young Rha

2021Cancer Research and Treatment20 citationsDOIOpen Access PDF

Abstract

At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.

Topics & Concepts

MedicinePandemicCoronavirus disease 2019 (COVID-19)PneumoniaOutbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseCancer2019-20 coronavirus outbreakCoronavirusTask forceIntensive care medicineClinical PracticeMEDLINEFamily medicineInfectious disease (medical specialty)VirologyInternal medicinePublic administrationLawPolitical scienceCOVID-19 and healthcare impactsEconomic and Financial Impacts of CancerHealthcare cost, quality, practices
Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea | Litcius